Skip to search.
 TSX Up 0.84% TSX Ventures  0.00%
Streaming
Ticker Tape: On

RXi Pharmaceuticals Corporation (RXII)

-OTC Markets

0.20 May 17, 3:57PM EDT|Pre-Market : NaN

Add to Portfolio
Prev Close:0.20
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:0.05 - 0.36
Volume:0
Avg Vol (3m):1,519,710
Market Cap:67.63M
P/E (ttm):N/A
EPS (ttm):-0.13
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
RXII 0.00%67.63M
PFZ.L 0.00%173.71B
GSK.LUp 0.50%83.37B
AZN.LDown 0.28%42.17B
JNJ.MXUp 0.01%3.00T

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):450.87
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

RXi Pharmaceuticals Corporation discovers, develops, and commercializes therapies based on its RNAi platform. It provides RXI-109, a self-delivering RNAi compound (sd-rxRNA) for the reduction of dermal scarring in planned surgeries, as well as red... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback